CHTP Financial Facts
Operating loss: -8.08MResearch and development: 4.22M
See Full Income Statement
Other accrued expenses: 1.58M
Accrued contract research and manufacturing: 204.04K
See Full Balance Sheet
Chelsea Therapeutics International (CHTP) Earnings
|
Expand Research on CHTP
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +19.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/11/14 | Q413 | -$0.07 | -$0.07 | $0.00 | N/A | N/A | N/A |  | | Details | |
| 5/1/13 | Q113 | -$0.06 | -$0.05 | -$0.01 | N/A | N/A | N/A | | | Details | |
3/7/13  |
Q412 | -$0.03 | -$0.08 | +$0.05 | N/A | N/A | N/A | | | Details | |
| 8/7/12 |
Q212 | -$0.12 | -$0.19 | +$0.07 | N/A | N/A | N/A | | | Details | |
| 3/6/12 |
 |
Q411 | -$0.20 | -$0.32 | +$0.12 | N/A | N/A | N/A | | | Details |
| 11/2/11 |
|
Q311 | -$0.18 | -$0.27 | +$0.09 | N/A | N/A | N/A | | | Details |
| 7/26/11 |
|
Q211 | -$0.21 | -$0.25 | +$0.04 | N/A | N/A | N/A | | | Details |
| 5/9/11 |
|
Q111 | -$0.25 | -$0.23 | -$0.02 | N/A | N/A | N/A | | | Details |
